Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$760,639
-$176,587 QoQ
Shares Held
31,588
-5.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,483
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bedel Financial Consulting, Inc. holds $404,013,991 across 11 Drug Manufacturers - General names. PFE ranks #5 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
328,198 | $393,650,559 | |
| 2 | JNJ |
Johnson & Johnson
|
13,084 | $3,322,943 | |
| 3 | ABBV |
AbbVie Inc.
|
11,757 | $2,958,531 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,015 | $901,427 | |
| 5 | PFE |
Pfizer Inc
This page
|
31,588 | $760,639 | |
| 6 | NVS |
Novartis AG
|
4,326 | $677,970 | |
| 7 | AMGN |
Amgen Inc
|
1,648 | $596,773 | |
| 8 | GSK |
GSK plc
|
7,562 | $396,400 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $760,639 | 31,588 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $937,226 | 33,377 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $834,498 | 33,514 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $893,023 | 35,048 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $884,008 | 36,469 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $931,853 | 36,774 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $923,880 | 34,824 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $853,585 | 29,495 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $782,684 | 27,973 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $774,308 | 27,903 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $802,492 | 27,874 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $977,685 | 29,475 | Shares | Sole | 2024-02-08 | |
| 2023-06-30 | $1,090,826 | 29,739 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,149,254 | 28,168 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,465,771 | 28,606 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,181,607 | 27,002 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,318,404 | 25,146 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,180,356 | 22,800 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,300,517 | 22,024 | Shares | Other | 2022-01-11 | |
| 2021-09-30 | $938,134 | 21,812 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $858,935 | 21,934 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $744,780 | 20,557 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $655,954 | 17,820 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $647,937 | 17,655 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $574,049 | 17,555 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $614,186 | 18,817 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||